Implications of insecticide resistance for malaria vector control with long-lasting insecticidal nets: trends in pyrethroid resistance during a WHO-coordinated multicountry prospective study by Donnelly, Martin
Parasites & Vectors
 
Implications of insecticide resistance for malaria vector control with long-lasting
insecticidal nets: trends in pyrethroid resistance during a WHO-coordinated multi-
country prospective study
--Manuscript Draft--
 
Manuscript Number: PARV-D-18-00506R2
Full Title: Implications of insecticide resistance for malaria vector control with long-lasting
insecticidal nets: trends in pyrethroid resistance during a WHO-coordinated multi-
country prospective study
Article Type: Research
Section/Category: Protozoan Biology and Disease
Funding Information: Bill and Melinda Gates Foundation Not applicable
Department for International Development Not applicable
Medical Research Council Not applicable
Abstract: Abstract
Background: Increasing pyrethroid resistance has been an undesirable correlate of the
rapid increase in coverage of insecticide-treated nets (ITNs) since 2000. Whilst
monitoring of resistance levels has increased markedly over this period, longitudinal
monitoring is still lacking, meaning the temporal and spatial dynamics of phenotypic
resistance in the context of increasing ITN coverage are unclear.
Methods: As part of a large WHO-co-ordinated epidemiological study investigating the
impact of resistance on malaria infection, longitudinal monitoring of phenotypic
resistance to pyrethroids was undertaken in 290 clusters across Benin, Cameroon,
India, Kenya and Sudan. Mortality in response to pyrethroids in the major anopheline
vectors in each location was recorded during consecutive years using standard WHO
test procedures. Trends in mosquito mortality were examined using generalised linear
mixed-effect models.
Results: Insecticide resistance (using the WHO definition of mortality < 90%) was
detected in clusters in all countries across the study period. The highest mosquito
mortality (lowest resistance frequency) was consistently reported from India, in an area
where ITNs had only recently been introduced. Substantial temporal and spatial
variation was evident in mortality measures in all countries. Overall, a trend of
decreasing mosquito mortality (increasing resistance frequency) was recorded (Odds
Ratio per year: 0.79 per year (95% CI: 0.79–0.81, P < 0.001). There was also evidence
that higher net usage was associated with lower mosquito mortality in some countries.
Discussion: Pyrethroid resistance increased over the study duration in four out of five
countries. Insecticide-based vector control may be compromised as a result of ever
higher resistance frequencies.
Corresponding Author: Jackie Cook, Phd
London School of Hygiene and Tropical Medicine
UNITED KINGDOM
Corresponding Author Secondary
Information:
Corresponding Author's Institution: London School of Hygiene and Tropical Medicine
Corresponding Author's Secondary
Institution:
First Author: Jackie Cook (on behalf of consortium)
First Author Secondary Information:
Order of Authors: Jackie Cook (on behalf of consortium)
Order of Authors Secondary Information:
Response to Reviewers: Hi, I have adapted the author details as requested following communication with Aneta
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Kostadinova- please let me know if anything needs changing with them.  We sent
better quality figures with the last submission- when I download these, they look fine-
but in the submission, they are a bit blurry- could you please let me know if you need
improved quality on them.  Thanks in advance, Best wishes, Jackie
Additional Information:
Question Response
<b>Is this study a clinical
trial?</b><hr><i>A clinical trial is defined
by the Word Health Organisation as 'any
research study that prospectively assigns
human participants or groups of humans
to one or more health-related
interventions to evaluate the effects on
health outcomes'.</i>
No
Are you submitting to an Article
Collection?
No
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
  
Implications of insecticide resistance for malaria vector control with long-
lasting insecticidal nets: trends in pyrethroid resistance during a WHO-
coordinated multi-country prospective study 
 
Implications of Insecticide Resistance Consortium*  
*Correspondence:  Jackie.Cook@lshtm.ac.uk 
Email addresses: 
Jackie Cook: Jackie.Cook@lshtm.ac.uk 
Sean Tomlinson: sean.tomlinson@lstmed.ac.uk 
Immo Kleinschmidt: Immo.Kleinschmidt@lshtm.ac.uk  
Martin James Donnelly: martin.donnelly@lstmed.ac.uk 
Martin Akogbeto: akogbetom@yahoo.fr 
Alioun Adechoubou: aliounadechoubou@hotmail.com 
Achile Massougbodji: massougbodjiachille@yahoo.fr  
Mariam Okê-Sopoh: mariamoke@yahoo.fr 
Vincent Corbel: vincent.corbel@ird.fr 
Sylvie Cornelie: sylvie.cornelie@ird.fr 
Aurore Hounto: aurorefel@yahoo.fr 
Josiane Etang: josyet2@gmail.com 
Herman Parfait Awono-Ambene: hpaawono@yahoo.fr 
Jude Bigoga: jbigoga@gmail.com 
Stanislas Elysée Mandeng: mandengelysee@yahoo.fr 
Boris Njeambosay: njoboris@gmail.com 
Raymond Tabue: tnraymon@yahoo.fr 
Celestin Kouambeng: kouambeng@gmail.com 
Manuscript Click here to access/download;Manuscript;PARV-D-18-
00506_R1 EDIT SG JC.docx
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  
Etienne Fondjo: fondjoetienne@yahoo.fr 
Kamaraju Raghavendra: kamarajur2000@yahoo.com 
Rajendra M Bhatt: rmbhatt@rediffmail.com 
Mehul Kumar Chourasia: mehul4frnds@gmail.com 
Dipak K. Swain: dipakswain@gmail.com 
Sreehari Uragayala: sreeuragayala2008@gmail.com 
Neena Valecha: neenavalecha@gmail.com  
Charles Mbogo: CMbogo@kemri-wellcome.org 
Nabie Bayoh: NBayoh@kemricdc.org 
Teresa Kinyari: teresakinyari@yahoo.com 
Kiambo Njagi: knjagi@domckenya.or.ke 
Lawrence Muthami: muthamilawrence@yahoo.com 
Luna Kamau: LKamau@kemri.org 
Evan Mathenge: mathengeevan@gmail.com 
Eric Ochomo: EOchomo@kemricdc.org 
Hmooda Toto Kafy: hmoodatuok@gmail.com  
Adam Ismail Bashir: bashiradam69@yahoo.co.uk 
Elfatih M Malik: fatihmmalik@gmail.com 
Khalid Elmardi: khalid.elmardi@gmail.com 
Jihad Eltaher Sulieman: jihadmia@hotmail.com  
Mujahid Abdin: Mogahid_Abdin@live.com  
Krishanthi Subramaniam: Krishanthi.Subramaniam@lstmed.ac.uk 
Brent Thomas: brent.thomas@lstmed.ac.uk  
Philippa West: pippawest@hotmail.co.uk 
John Bradley: John.Bradley@lshtm.ac.uk 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  
Tessa Bellamy Knox: knoxt@who.int  
Abraham Peter Mnzava: AMnzava@alma2030.org 
Jonathan Lines: Jo.Lines@lshtm.ac.uk 
Michael Macdonald: macdonaldm@macito.net    
Zinga José Nkuni: nkuni50@yahoo.com 
 
 
 
 
 
 
Abstract 
Background: Increasing pyrethroid resistance has been an undesirable correlate of the rapid 
increase in coverage of insecticide-treated nets (ITNs) since 2000. Whilst monitoring of 
resistance levels has increased markedly over this period, longitudinal monitoring is still 
lacking, meaning the temporal and spatial dynamics of phenotypic resistance in the context of 
increasing ITN coverage are unclear. 
Methods: As part of a large WHO-co-ordinated epidemiological study investigating the 
impact of resistance on malaria infection, longitudinal monitoring of phenotypic resistance to 
pyrethroids was undertaken in 290 clusters across Benin, Cameroon, India, Kenya and Sudan. 
Mortality in response to pyrethroids in the major anopheline vectors in each location was 
recorded during consecutive years using standard WHO test procedures. Trends in mosquito 
mortality were examined using generalised linear mixed-effect models. 
Results: Insecticide resistance (using the WHO definition of mortality < 90%) was detected 
in clusters in all countries across the study period. The highest mosquito mortality (lowest 
resistance frequency) was consistently reported from India, in an area where ITNs had only 
recently been introduced. Substantial temporal and spatial variation was evident in mortality 
measures in all countries. Overall, a trend of decreasing mosquito mortality (increasing 
resistance frequency) was recorded (Odds Ratio per year: 0.79 per year (95% CI: 0.79–0.81, 
P < 0.001). There was also evidence that higher net usage was associated with lower 
mosquito mortality in some countries.   
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Discussion: Pyrethroid resistance increased over the study duration in four out of five 
countries. Insecticide-based vector control may be compromised as a result of ever higher 
resistance frequencies.   
Keywords: Malaria, Vector control, Insecticide resistance, Trends, Bednets, Bioassay 
 
 
Background 
Vector control using indoor residual spraying (IRS) and insecticide-treated nets (ITNs) are 
core strategies for malaria control and elimination. The huge scale-up of these interventions 
in the last 20 years has been associated with major reductions in disease burden [1]. Between 
2000 and 2015, it is estimated that over 1 billion ITNs were distributed in malaria endemic 
countries. The proportion of people in sub-Saharan Africa sleeping under a net increased 
from 30 to 54% between 2010 and 2016, whilst in 2016 an estimated 2.9% of the at-risk 
population was covered by IRS globally [1]. The increased coverage of vector control is 
estimated to have been a major contributor to the documented 62% decline in malaria 
mortality between 2000–2015 [2, 3]. However, between 2015 and 2016, data suggest that 
malaria mortality have remained the same in the WHO regions of Southeast Asia, the 
Western Pacific and Africa, and possibly increased in the Eastern Mediterranean and the 
Americas [1]. There are therefore justified concerns about the emergence and spread of 
insecticide resistance and the impact this may have on the continued effectiveness of 
insecticide-based interventions [1, 4].  
Resistance has now been detected in malaria vectors to the four classes of public 
health insecticides used in malaria vector control (pyrethroids, organochlorines, 
organophosphates and carbamates) [5], and up to October 2016 had been reported in 71 
malaria-endemic countries [6]. Until recently, pyrethroids have been the only class used for 
long-lasting insecticidal nets (LLINs) and accounted for a large proportion of the insecticide 
used for IRS. This heavy reliance on a single insecticide class prompted the World Health 
Organization (WHO) to issue a Global Plan for Insecticide Resistance Management (GPIRM) 
[5] which was subsequently expanded as part of the Global Vector Control Response [7]. The 
aim of these initiatives is to sustain the advances made in the fight against vector-borne 
disease through rational use of vector control tools, including insecticide deployment to slow 
the development of resistance. Country-level implementation of recommended activities and 
monitoring has been poor due to a combination of limited availability and costs of 
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insecticides with new modes of action; human, financial and infrastructural capacity 
shortfalls; and insufficient data to determine epidemiological impact of insecticide resistance 
[8]. To address this latter point the WHO, with funding from the Bill and Melinda Gates 
Foundation, initiated a multi-country prospective study to assess the impact of insecticide 
resistance on the effectiveness of LLINs and IRS. The main objectives of the study were: (i) 
to determine the impact of insecticide resistance in malaria vectors on the protective 
effectiveness of LLINs and IRS, and hence on malaria disease burden; and (ii) to assess 
trends in the insecticide resistance status and underlying mechanisms in the main malaria 
vector species from the study areas in response to different interventions. 
The study was conducted in five countries, Benin, Cameroon, India, Kenya and 
Sudan, with data collection conducted from 2010–2016. Details of the overall study design 
are given in Kleinschmidt et al. [9]. Overall epidemiological outcomes, presented in 
Kleinschmidt et al. [10], showed that nets provided protection against malaria irrespective of 
resistance frequency, indicating that populations in malaria endemic areas should continue to 
use LLINs to reduce their risk of infection. A number of country-specific analyses from this 
and other studies corroborate this finding [11–15]. In addition, several studies have published 
country-specific entomological data relating to the second objective [16–18], with ranges of 
resistance to pyrethroids reported. In this paper, we describe temporal and spatial trends in 
insecticide resistance of the main malaria vector species from across the five study countries. 
 
 
Methods 
Study design 
The overall study design is described in detail in Kleinschmidt et al. [9]. The five countries 
included in the study were selected to represent areas of varying transmission intensity where 
resistance had previously been detected in malaria vectors (Table 1). In 279 study clusters 
(villages or groups of villages) across 16 areas in the five countries pyrethroid susceptibility 
in malaria vectors, and malaria infection and disease in children were measured 
simultaneously over several years. We aimed to assess whether higher levels of resistance are 
associated with loss of effectiveness of LLINs, and to characterise temporal and spatial trends 
in insecticide resistance. The numbers of clusters chosen per country are shown in Table 1 
and were based on sample size calculations determined by the epidemiological outcomes [9]. 
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Clusters were defined as villages or groups of hamlets with no less than 500 houses and were 
at least 2 km apart to avoid spill over in outcomes between clusters. 
 
Vector control 
LLIN mass distributions were carried out routinely in each site to provide universal coverage 
for each household (one net per two persons). Nets were distributed in Benin in 2011 (Olyset 
Net®, Sumitomo Chemical, Tokyo, Japan; 1 g/m2 permethrin) and 2014 (PermaNet® 2.0, 
Vestergaard, Lausanne, Switzerland; 55 mg/m2 deltamethrin), in Cameroon in 2011 and 2015 
(PermaNet® 2.0), in India in 2014 (PermaNet® 2.0), in Kenya in 2010 and 2013 
(PermaNet® 2.0), and in Sudan in 2011 and 2014 (PermaNet® 2.0). Net usage, defined as the 
proportion of respondents reporting as having slept under an LLIN the previous night, was 
determined through cross-sectional surveys which took place at least once in each country 
during the study period [10]. Cross-sectional household surveys, which consisted of sampling 
children from random households occurred in 2012 (Kenya, Sudan), 2013 (Cameroon, 
Sudan), 2014 (Sudan), 2015 (Benin, India) and 2016 (India) [10]. We used net usage as a 
proxy for the level of local mosquito exposure to pyrethroids. In Sudan half of the clusters 
were randomised to receive two rounds of IRS with bendiocarb (Ficam®80% WP, Bayer, 
Leverkusen, Germany; 200 mg active ingredient/m2. An exception was the Galabat region 
where clusters received IRS with deltamethrin (25 mg of a.i./m2; Chema Industries, 
Alexandria, Egypt) before changing to bendiocarb in subsequent years [15].  
 
Measuring resistance 
Phenotypic susceptibility to the pyrethroid deltamethrin, in the main local vector(s), was 
measured annually in each cluster using WHO adult susceptibility tests and recorded as 
percent mortality [19]. In Benin, Cameroon, Kenya and Sudan larvae were collected from 
breeding sites within each cluster annually and reared to adulthood in insectaries. In India, 
where larval sites were difficult to locate, resting females were caught [19]. Adult female 
mosquitoes [of unknown age (India); 2–5 days-old (all other countries)] were exposed for 60 
minutes to deltamethrin using WHO impregnated papers at standard concentrations (0.05% 
deltamethrin). Mosquitoes were kept at temperatures between 23 and 27 °C, with humidity, 
where measured, between 75–85%. Mortality was measured 24 h post-exposure. In all tests, 
observed mortality in control mosquitoes was less than 5% therefore Abbott’s correction was 
not applied.  
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Statistical analysis 
Mosquito mortality data were analysed at the level of the individual mosquito, with post-
exposure status (dead/alive after 24 h) modelled as the response variable in logistic 
regression. Explanatory variables of interest were year, years since last LLIN distribution, 
and cluster- and year-specific LLIN use as measured in cross-sectional household surveys. 
Susceptibility test data were excluded from the analysis if fewer than 40 mosquitoes were 
tested. A mortality estimate was calculated per cluster for each time point, with data for each 
country analysed separately and in an all-country model. Association between cluster 
mortality estimates was assessed between years using binomial generalised linear models. 
Separate generalised mixed-effect models were used to assess trends in mortality over time, 
effect of time since LLIN mass distribution and effect of bednet use, with the cluster 
specified as the random effect to account for within cluster correlation of responses. Year was 
modelled as a linear term to investigate trends over time. Where appropriate, a regional 
identifier was included as a fixed effect to allow for spatial differences in resistance within 
countries. Where data were available, insectary temperature and humidity during resistance 
testing were included in country-level models (Cameroon, India, Sudan). 
Cluster-level net usage, as a categorical variable (low, < 40%; medium, 40–80%; and 
high, > 80%), was explored as an explanatory variable in the years where these data were 
available from concurrent cross-sectional surveys. As bednet usage was only available for 
some years, a time variable was not included in these models. To investigate whether the 
impact of bednet distributions waned over time, models using time since bednet distribution 
(in years) as the key explanatory variable (as opposed to calendar time) were also examined.   
Data from all 5 countries were combined to investigate whether there was evidence 
for an overall temporal trend in phenotypic resistance, with country added as a fixed effect. 
As the only data available from 2016 were from India, the all-country analysis was 
undertaken with and without India.   
Results are presented in terms of changes in mortality of mosquitoes by year [Odds 
Ratios (OR) per year] or with increasing cluster-level category of net usage, with a reduction 
in mortality indicative of increasing resistance frequency.   
 
 
Results 
Estimates of mortality 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  
More than 90,000 mosquitoes were tested in 911 separate tests across 5 countries and over 6 
years. The median number of mosquitoes exposed per cluster per year was 100 [interquartile 
range (IQR) 84–104]. Median mortality across all tests was 81% (IQR: 63–94%). Insecticide 
resistance, classified according to the WHO criteria of < 90% mortality, was detected in all 
tested species, in all five countries and in 87% (n = 793) of tests performed. In only 7% of 
tests performed (n = 63, from 57 clusters) was 100% mortality observed. There were 
noticeable differences in the proportions of clusters defined as susceptible across countries. 
For example, in India, ≥ 98% mortality was observed in 28% (n = 66) of tests compared to 
only 1% of tests (n = 2) in Sudan. In Benin, Cameroon, Kenya and Sudan, > 50% mortality 
was recorded in at least 14% of tests recorded; no tests in India had less than 50% mortality.   
 
Temporal and spatial variation 
Cluster-specific mosquito mortality showed limited and inconsistent evidence of year-to-year 
correlation in all countries (Fig. 1). The strongest association was seen between data points 
from 2014 and 2015 (Kendall's tau coefficient: 0.42, P < 0.001), although this pattern 
differed by country, with no correlation seen between those years in Benin or India (Sudan 
ceased data collection in 2014) (Kendall's tau coefficient 0.07, P = 0.677, and 0.02, P = 
0.886, respectively). The strongest correlation between years was seen in Cameroon, with 
Kendall's tau coefficient > 0.3 for all year pairs (P < 0.02), whilst for the other countries 
correlation was only present in some pairwise comparisons. 
 
Trends in mortality over time 
The trends in mortality over the study period differed by country (Table 2, Fig. 2). A decrease 
in mortality was detected in Benin, Cameroon, Kenya and Sudan. A slight increase in 
mortality was detected in India (aOR: 1.03 (95% CI: 0.98–1.1), P = 0.08). The most 
substantial yearly decrease was detected in Sudan (aOR: 0.67 (95% CI: 0.64–0.70), P < 
0.001). With data from all countries combined, a 21% decrease per year in odds of mortality 
was detected (aOR 0.79 (95% CI: 0.79–0.81), P < 0.001). This was not substantially altered 
with the exclusion of India (aOR 0.77 (95% CI: 0.76–0.79), P < 0.001). 
 
Effect of bednet distributions and bednet use 
Bednet distributions occurred in all sites during the study period. Associations between 
bednet usage and cluster specific mosquito mortality was investigated for each year that 
epidemiological cross-sectional data were available. Mean net use was above 65% in all 
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countries, with Kenya reporting the highest value (94.2%). Benin, India and Kenya had no 
clusters with less than 40% net usage. Net usage appeared to have differential impact on 
mosquito mortality in each country with no association found in Benin and Kenya (P = 0.225 
and P = 0.241, respectively); higher mortality found in areas with higher net usage in 
Cameroon (aOR 1.6 and 1.4 for net usage between 40–80% and above 80% respectively, 
compared to clusters with net use under 40%, P < 0.001) and strong negative associations 
found in India and Sudan (Table 3).   
Time since bednet distribution was also investigated to establish whether changes 
associated with bednet distributions waned over time. Differential trends were evident with 
Benin, India and Sudan demonstrating an increase in odds of mortality (decreasing resistance 
frequency) for each year post-distribution (P < 0.001 for each) whereas mosquito mortality in 
Cameroon (aOR: 0.95, P = 0.016) and Kenya (aOR:  0.59; P < 0.001) decreased (increased 
resistance frequency) with each year post-LLIN distribution (Table 4).   
 
 
Discussion 
Insecticides have been a key component in the public health and agriculture toolbox for over 
a century, resulting in the inevitable emergence of resistance in mosquito vectors. This study 
brings together a very large collection of data from a range of transmission settings to 
investigate the trends in pyrethroid resistance. Whilst year to year variation was substantial, 
and poor inter-year correlation prevented cluster specific predictions of resistance, a decrease 
in mosquito mortality was detected in 4 out of the 5 countries over the 5-year period of the 
study suggesting that resistance to pyrethroids has been gradually increasing in these settings.  
WHO encourages regular monitoring of resistance frequencies to all insecticides used 
in country. Consequently, the level of reporting has increased dramatically in recent years 
with over 30,000 data points now entered into global databases such as the WHO Malaria 
Threats Map [20] and IR-mapper (www.irmapper.com) [21]. The picture that emerges from 
these summary data [6, 22, 23], as with the present study, is that resistance to pyrethroids is 
increasing in frequency and geographic extent. However, these global databases often 
aggregate data with substantially differential sampling effort across years and regions [6] 
which may obscure the substantial stochasticity in mortality estimates.   
It is assumed that the increase in resistance to pyrethroids over the past decade is due 
in part to the higher coverage of insecticide-based interventions, such as LLINs. However, 
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studies have shown conflicting results with some reports of increasing resistance following 
bednet distributions [24–27], and other reports of no increases despite sustained insecticidal 
campaigns [28–30]. Although ascertaining the effect of bednet coverage was not a primary 
goal of this study, it was possible to investigate the impact of net use through cross-sectional 
surveys that were conducted concurrently to resistance measurements. Trends were not 
uniform across countries, perhaps in part reflecting the differing biology of the vector 
species. Anopheles arabiensis (a major vector in Kenya, Cameroon and Sudan study 
locations) and An. culicifacies (primary vector in India study locations) commonly show high 
rates of zoophily. Obtaining blood meals from sources other than humans means LLINs 
would potentially have less impact on selective pressure on resistance. However, overall, 
higher net usage was associated with increasing resistance in mosquitoes. This trend was 
most evident in Sudan where the widest range of net usage was reported whereas in other 
settings reported net usage was more uniform, thereby reducing the likelihood of detecting a 
trend.     
We did not discern a consistent trend in mosquito mortality with increasing time post-
net distribution. In Benin, India and Sudan, mortality increased every year post-distribution, 
suggesting that the initial increased coverage of nets may have been a short-term driver for 
resistance and that as the insecticide on the nets reduced over time, the selection pressure 
reduced, in turn reducing the proportion of resistant mosquitoes. However, in Cameroon and 
Kenya, the opposite effect was observed, with mortality decreasing with every year from the 
date of the distribution. Data from the An. gambiae 1000 genome project has revealed that 
there appear to be numerous instances of localised adaptation to insecticide pressure [31]. 
The difference we observed in response to LLIN distribution may reflect in part this innate 
difference of vector populations to respond to insecticide pressure and caution against making 
generalised predictions. 
Moreover, whilst bednet distributions will have increased selection pressure in the 
study settings, it is also possible that the insecticide resistance could be linked to ongoing 
agricultural practices [32–34]. In several African countries, including northern Cameroon, the 
use of pyrethroids for cotton farming has been implicated as a catalyst for the increase in 
recorded resistance in An. gambiae populations [34–36]. Differences in the use of pyrethroids 
for agricultural purposes in the study settings could further impact the relationship between 
time of net distribution and insecticide resistance.   
Previous studies have also shown resistance to be highly focal [16, 37–39], with large 
variations over small geographical distances. This is exemplified by the range of mortality 
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measures within each country and highlights the need for multiple sentinel monitoring sites 
per country and reinforces that extrapolating resistance data from few, widely-dispersed 
sentinel sites to larger areas is untenable. Spatial heterogeneity in insecticide resistance poses 
challenges for integrated resistance management and suggests that locally tailored vector 
control and resistance management programmes are required.  
There was considerable temporal heterogeneity with high between year variation at 
cluster level. This phenomenon has also been reported elsewhere [40–43]. There are several 
reasons why levels of resistance in a mosquito population may fluctuate over time, for 
instance, resistance can recede if proper resistance management practices are implemented or 
if resistance drivers reduce and resistance associated genetic variants are deleterious in the 
absence of selection pressure [5, 44]. It is possible that in our study settings varying exposure 
to pyrethroids resulted in fluctuating frequency of resistance in the mosquito population with 
evidence from some areas suggesting that bednet usage resulted in higher resistance 
frequencies.   
As well as genuine fluctuations in the frequency of resistance, it is possible that the 
different susceptibility recorded is, in part, an artefact of the method of testing. Longitudinal 
monitoring is easily influenced by any changes in protocol for measuring mortality and the 
timings of the tests. Some studies have demonstrated fluctuations in mosquito mortality over 
a transmission season [45] and whilst all efforts were taken to ensure that tests occurred at the 
same time each year, differences between seasons may have had an impact. In addition, 
humidity and temperature are known to have an impact on mortality testing [46]; whilst these 
were controlled for where data were available, it is possible that differing conditions 
influenced mortality results.   
There is mounting evidence that tests recording mosquito mortality after 24 h may not 
be the best way to record changes in population resistance, particularly when the level of 
resistance is high [47]. A number of alternative options are now available for monitoring the 
presence of resistance, including molecular assays, time/dose response assays and increasing 
the time post-exposure at which mortality is calculated all of which are likely to be more 
sensitive to resistance trends [48–51], but these methods are also more resource intensive. 
Although as noted by Churcher et al. [4] the strong association between bioassay data and 
mortality measured in experimental hut trials supports the use of bioassays as a quantitative 
test of the impact of resistance on LLIN efficacy. In this multi-country study, to ensure 
comparability between sites, the test was performed using one insecticide dose and one 
exposure time, using wild-caught mosquitoes reared in the laboratory. These settings may not 
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reflect adequately the conditions wild mosquitoes experience, such as variations in 
temperature, food availability and pre-existing pesticide exposure [51]. In addition, the doses 
used in the resistance tests are not necessarily reflective of the doses mosquitoes would 
experience in the wild, which can be influenced by age or retreatment of ITN or regularity 
and coverage of IRS. The dose used for detecting resistance can have a particularly strong 
effect depending on the prevalence and penetrance of the resistant mechanisms present in the 
mosquito population. Recording mortality at 24 h may also miss some of the nuances 
involved with the evolution of resistance which may result in delayed mortality [51]. In 
addition, mosquito age has been shown to have a big impact on susceptibility, with older 
mosquitoes showing higher mortality rates compared to their younger counterparts [52]. If 
insecticides remain effective against mosquitoes old enough to transmit malaria, this may 
explain why some studies are observing minimal impact on epidemiological outcomes [10–
12, 14).   
 
 
Conclusions  
This study demonstrated increasing frequency of resistance to pyrethroids in malaria vectors 
from 4 out of 5 study countries. Although the increase does not appear linear, if the current 
trend continues, it is likely to result in a reduction of the effectiveness of pyrethroid-based 
interventions such as ITN and IRS. There was evidence in some countries of increased 
selection pressure for pyrethroid resistance in clusters where net use was higher. There are a 
number of strategies presented within GPIRM to mitigate the increase of insecticide 
resistance in malaria vectors such as rotations, combinations, mosaics and mixtures [5]. In the 
short term, two trials have demonstrated improved efficacy of dual-active [53] and 
pyrethroid-PBO treated LLINs [54], suggesting that we are likely to be able to prolong the 
useful active life of pyrethroid-based interventions. However, the lack of vector control tools 
with different modes of actions and their increased costs, means that many endemic countries 
will continue to struggle to develop and implement insecticide resistance management plans. 
Whilst new products are currently being trialled [55–57], and some have recently come to 
market, the fine-scale monitoring of resistance phenotypes and mechanisms will be key to 
mitigating the impacts of insecticide resistance through informed selection of vector control 
tools.   
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Figure legends 
Fig. 1 Association in cluster mortality between years. Scatter diagrams show results for 
clusters with mortality estimates in consecutive years for each year of the study. The 
predicted mortality result from binomial generalised linear models is overlaid on each graph 
with 95% confidence intervals 
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Fig. 2 Box-and-whisker plots showing the range of cluster-level mortality by year and 
country. Arrows indicate the timing of bednet distributions within country 
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Table 1 Details of study sampling and sites including vector control coverage and insecticide 
resistance prevalence at baseline  
 Study sampling sites 
 Benin Cameroon India Kenya Sudan 
Malaria 
transmission 
intensity 
High High Low High Low 
Study locations Districts of 
Ifangni, Sakété, 
Pobé and Kétou 
(Departement de 
Plateau) 
Districts of 
Garoua, Pitoa 
and Mayo Oulo 
(North region) 
Subdistrict of 
Keshkal 
(Kondagaon, 
Chhattisgarh) 
Districts of 
Teso, 
Rachuonyo, 
Nyando and 
Bondo (western 
Kenya) 
El Hoosh and 
Hag Abdalla 
(Gezira State); 
Galabat 
(Gedarif State; 
New Halfa 
(Kassala State) 
Number of clusters 
sampled 
32 38 80 61 79 
Entomological 
sampling points 
(years) 
2011–2015 2012–2015 2013–2016 2011–2015 2011–2014 
Main malaria 
vectors 
Anopheles 
gambiae (s.s.)a, 
Anopheles 
coluzziia 
An. arabiensisa, 
An. gambiae 
(s.s.)a, An. 
funestus 
An. culicfaciesa An. gambiae 
(s.s.)a, An. 
arabiensisa, An. 
funestus 
An. arabiensisa 
Vector control 
interventions 
High coverage of 
ITNs (primarily 
PermaNet 2.0) in 
all clusters 
High coverage 
of ITNs 
(PermaNet 2.0) 
in all clusters 
High coverage 
of ITNs 
(PermaNet 2.0) 
in all clusters 
High coverage 
of ITNs 
(PermaNet 2.0 
and Olyset Net) 
in all clusters. 
Rachuonyo and 
Nyando 
received IRS 
with 
deltamethrin and 
lambda-
cyhalothrin in 
2012, but no 
IRS was carried 
out subsequently 
High coverage 
of ITNs 
(PermaNet 2.0) 
in all study 
clusters. In each 
study area half 
of clusters 
randomly 
allocated to 
receive 
additional IRS 
with bendiocarb 
Baseline 
insecticide 
resistance 
Kdr frequency 
by cluster ranged 
from 44 to 93% 
Kdr frequency 
by cluster 
ranged from 9 
WHO Bioassay 
mortality to 
deltamethrin 
WHO Bioassay 
mortality to 
deltamethrin 
Kdr frequency 
by cluster 
ranged from 8.3 
Tables Click here to access/download;Table;PARV-D-18-00506_R1
Tables EDIT SG JC.docx
information 
(cluster-specific 
range) 
(2011) WHO 
Bioassay 
mortality to 
deltamethrin 
ranged between 
20–100% (2011) 
to 65% (2011) 
WHO Bioassay 
mortality to 
deltamethrin 
ranged between 
43–100% 
(2012) 
ranged between 
86–100% 
ranged between 
1–100% (2011) 
to 70.8% 
(2010); WHO 
Bioassay 
mortality to 
deltamethrin in 
sentinel clusters 
ranged between 
47–100% 
(2011) 
aMortality results in paper presented for these species 
  
Table 2 Impact of time on mosquito mortality. Results from generalised linear mixed-effect models 
examining the impact on mosquito mortality over time (year)  
Country Odds ratio for change in 
mortality per year (95% CI) 
P-value 
All five countries combineda 0.79 (0.79–0.81) <0.001 
Four countries combined 
(without India)a 
0.77 (0.76–0.79) <0.001 
Beninb 0.74 (0.72–0.76) <0.001 
Cameroonc 0.74 (0.69–0.78) <0.001 
Indiac 1.03 (0.98–1.1) 0.08 
Kenyab 0.88 (0.86–0.90) <0.001 
Sudanc 0.67 (0.64–0.70) <0.001 
aAdjusted for country 
bAdjusted for district 
cAdjusted for district, temperature and humidity 
Results are presented in terms of change in odds of mortality of mosquitoes in WHO bioassays by 
year. Odds ratios are adjusted for locality and temperature and humidity where indicated. The data 
are shown for each country, as well as all countries combined (with country included as a 
covariate). Cluster was included as a random effect in all models 
 
  
Table 3 Impact of cluster-level bednet usage on mosquito mortality. Results from generalised 
mixed-effect models examining the impact of cluster-level bednet usage on mosquito mortality 
  All countries 
combineda 
Beninb Cameroonc Indiac Kenyab Sudanc 
 No. of 
clusters 
included 
(year) 
59 (2012); 87 
(2013); 143 
(2014); 99 
(2015); 80 
(2016) 
19 (2015) 22 (2013); 26 (2014) 80 (2015); 80 
(2016) 
13(2012); 41 (2014) 46 (2012); 65 
(2013); 76 (2014) 
 Mean net 
usage 
(range) 
(%) 
 74.9 (52.5–100) 67.8 (7.0–100) 89.9 (60.9–100) 94.2 (73.7–100) 78.6 (0–100) 
Effect of cluster-
level net usage on 
mosquito 
mortality, OR 
(95% CI) 
< 40% 1 (reference) – 1(reference) – – 1 (reference) 
 40–80% 1.03 (0.89–1.19) 1 (reference) 1.61 (1.21–2.14) 1 (reference) 1 (reference) 0.69 (0.58–0.83) 
 > 80% 0.65 (0.57–0.74) 1.59 (0.75–3.37) 1.40 (1.08–1.82) 0.36 (0.29–0.44) 2.38 (0.56–10.1) 0.45 (0.38–0.53) 
 P-value <0.001 0.225 <0.001 <0.001 0.241 <0.001 
aAdjusted for country 
bAdjusted for district  
cAdjusted for district, temperature and humidity 
Results are presented in terms of change in mortality of mosquitoes for increasing bednet usage 
category (< 40%; between 40–80%; and above 80%). Bednet usage was calculated for years where 
cross-sectional survey data was available. Odds ratios are adjusted for locality and temperature and 
humidity where indicated. The results are shown for each country, as well as all countries combined 
(with country included as a covariate). Cluster was included as a random effect in all models 
 
  
Table 4 Impact of time since bednet distribution (years) on mosquito mortality. Results from 
generalised mixed-effect models examining the impact time since bednet distribution on mosquito 
mortality 
Country Odds ratio for change in mortality 
per year (95% CI) 
P-value 
All countries combineda 1.34 (1.31–1.37) <0.001 
Beninb 3.20 (3.02–3.39) <0.001 
Cameroonc 0.95 (0.90–0.99) 0.016 
Indiac 1.62 (1.52–1.73) <0.001 
Kenyab 0.59 (0.56–0.62) <0.001 
Sudanc 1.60 (1.53–1.67) <0.001 
aAdjusted for country 
bAdjusted for district 
cAdjusted for district, temperature and humidity 
Results are presented in terms of change in mortality of mosquitoes for each year since a mass 
bednet distribution took place in-country. Odds ratios are adjusted for locality and temperature and 
humidity where indicated. The results are shown for each country, as well as all countries combined 
(with country included as a covariate). Cluster was included as a random effect in all models 
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